Seikagaku News and Activities
Presence
Seikagaku develops and sells specialty pharmaceutical and life science products, including treatments for osteoarthritis and spinal disorders, diagnostic reagents, and raw materials for medical use, serving hospitals, clinics, and healthcare companies.
Seikagaku products and services overview:
- Osteoarthritis treatments
- Spinal disorder drugs
- Diagnostic reagents
- Medical raw materials
- Life science materials
- Regenerative medicine support
Revenue: ~$260 million
Employees: 1,500
Headquarters: Tokyo, Japan
Seikagaku is one of the...
Seikagaku is a company listed under the stock ticker 4548 (JP).
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Seikagaku
- Ken Mizutani, President, Chief Director of Production and Represen...
- Shinkichi Matsuo, Supervisory Board Member
- Wakako Mitani, Supervisory Board Member
Create your alert
to follow the executive moves at Seikagaku.
Pharmaceuticals
Seikagaku has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Seikagaku
Social media about Seikagaku
- Seikagaku on Wikipedia, Google News & Yahoo Finance
- Seikagaku on LinkedIn, X (Twitter) & YouTube
